HRT Financial’s Ares Acquisition Corporation Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 AAC.WS Stock Holding History

HRT Financial’s Portfolio AAC.WS Stock Details AAC.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-21,947	Closed	-$14K	–	3348
2023 Q3	$14K	Hold	21,947	–	–	﹤0.01%	2102
2023 Q2	$17K	Hold	21,947	–	–	﹤0.01%	2116
2023 Q1	$19K	Hold	21,947	–	–	﹤0.01%	2187
2022 Q4	$10K	Buy	+21,947	New	+$4.3K	﹤0.01%	2225

HRT Financial's AAC.WS Position: Q4 2023 in Review

HRT Financial sold out of Ares Acquisition Corporation Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 (AAC.WS) in Q4 2023, closing a stake of 21,947 shares — an estimated $14K sold.

HRT Financial first reported a position in AAC.WS in Q4 2022 and held it in 4 quarters. The position peaked at $19K in Q1 2023. 0 funds tracked by Wall St. Rank hold AAC.WS as of Q4 2023.

HRT Financial reported no remaining Ares Acquisition Corporation Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position as of Q4 2023 after selling out during the quarter.
HRT Financial sold 21,947 Ares Acquisition Corporation Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 shares in Q4 2023, an estimated $14K.
HRT Financial first reported a position in Ares Acquisition Corporation Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 in Q4 2022 and held it in 4 quarters.
HRT Financial's Ares Acquisition Corporation Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position peaked at $19K in Q1 2023.
0 funds tracked by Wall St. Rank held Ares Acquisition Corporation Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 as of Q4 2023.

Based on HRT Financial's 13F filing for Q4 2023, filed 9 Feb 2024.